Global Birth Control Pills Market

Birth Control Pills Comprehensive Study by Type (Oral Contraceptives, Contraceptive Injectable), Application (Hospital Pharmacy, Independent Pharmacy, Online Platform, Clinics), Purchase Mode (Offline, Online) Players and Region - Global Market Outlook to 2026

Birth Control Pills Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Birth Control Pills are primarily used to prevent the unwanted pregnancy by blocking the normal process of ovulation or by altering the process which supports the fertilization of an egg. Most pills contain two sorts of manufactured (man-made) female hormones which are estrogen and progestin. They contain a small amount of man-made progestin and estrogen hormones. These hormones work to inhibit the natural cyclical hormones of the body to prevent pregnancy. The market of the birth control pills is increasing due to the growing need of population control and increasing incident of the abortion, but the rising occurrence of infertility amongst women is restricting the further use of birth control pills
According to AMA, the market for Birth Control Pills is expected to register a CAGR of 7.4% during the forecast period to 2026. This growth is primarily driven by Increasing need of population control and increasing incident of abortion, Governmental initiatives for minimizing unwanted pregnancy, and High incident rate of unintended pregnancies is leading to unmet birth control pills needs.

Globally, a noticeable market trend is evident Increasing awareness and healthcare expenditure, and increasing in use of birth control pills . The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Merck (United States), Pfizer (United States), Teva Pharmaceutical (Israel), Bayer (Germany), Allergan (Ireland), Janssen (United States), Mankind Pharma (India), Piramal Enterprises (India), Reckitt Benckiser (United Kingdom) and Church & Dwight (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:

FDA approves merck’s KEYTRUDA (pembrolizumab) for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic merkel cell carcinoma, a rare form of skin cancer

Regulatory Insights:
Government of various country and NGOs has taken initiatives of awareness programs which are promoting the use of contraceptive pills globally

Market Drivers
  • Increasing need of population control and increasing incident of abortion
  • Governmental initiatives for minimizing unwanted pregnancy,
  • High incident rate of unintended pregnancies is leading to unmet birth control pills needs

Market Trend
  • Increasing awareness and healthcare expenditure, and increasing in use of birth control pills
  • Increasing maternal age and late pregnancies

Restraints
  • Side effects associated with the use of birth control pills
  • cultural or religious opposition

Opportunities
Ethical and social issues restrict the use or subsidies on birth control pills in some countries and Presence of large unmet contraceptive needs in emerging Asian and African countries
Challenges
Rising occurrence of infertility amongst women is restricting the use of birth control pills and Social and ethical issues are expected to restrict the use of birth control pills in the near future

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Birth Control Pills Study Sheds Light on
— The Birth Control Pills Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Birth Control Pills industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Birth Control Pills industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Oral Contraceptives
  • Contraceptive Injectable
By Application
  • Hospital Pharmacy
  • Independent Pharmacy
  • Online Platform
  • Clinics
By Purchase Mode
  • Offline
  • Online

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing need of population control and increasing incident of abortion
      • 3.2.2. Governmental initiatives for minimizing unwanted pregnancy,
      • 3.2.3. High incident rate of unintended pregnancies is leading to unmet birth control pills needs
    • 3.3. Market Challenges
      • 3.3.1. Rising occurrence of infertility amongst women is restricting the use of birth control pills
      • 3.3.2. Social and ethical issues are expected to restrict the use of birth control pills in the near future
    • 3.4. Market Trends
      • 3.4.1. Increasing awareness and healthcare expenditure, and increasing in use of birth control pills
      • 3.4.2. Increasing maternal age and late pregnancies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Birth Control Pills, by Type, Application, Purchase Mode and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Birth Control Pills (Value)
      • 5.2.1. Global Birth Control Pills by: Type (Value)
        • 5.2.1.1. Oral Contraceptives
        • 5.2.1.2. Contraceptive Injectable
      • 5.2.2. Global Birth Control Pills by: Application (Value)
        • 5.2.2.1. Hospital Pharmacy
        • 5.2.2.2. Independent Pharmacy
        • 5.2.2.3. Online Platform
        • 5.2.2.4. Clinics
      • 5.2.3. Global Birth Control Pills by: Purchase Mode (Value)
        • 5.2.3.1. Offline
        • 5.2.3.2. Online
      • 5.2.4. Global Birth Control Pills Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Birth Control Pills (Price)
      • 5.3.1. Global Birth Control Pills by: Type (Price)
  • 6. Birth Control Pills: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceutical (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bayer (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Allergan (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Janssen (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mankind Pharma (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Piramal Enterprises (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Reckitt Benckiser (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Church & Dwight (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Birth Control Pills Sale, by Type, Application, Purchase Mode and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Birth Control Pills (Value)
      • 7.2.1. Global Birth Control Pills by: Type (Value)
        • 7.2.1.1. Oral Contraceptives
        • 7.2.1.2. Contraceptive Injectable
      • 7.2.2. Global Birth Control Pills by: Application (Value)
        • 7.2.2.1. Hospital Pharmacy
        • 7.2.2.2. Independent Pharmacy
        • 7.2.2.3. Online Platform
        • 7.2.2.4. Clinics
      • 7.2.3. Global Birth Control Pills by: Purchase Mode (Value)
        • 7.2.3.1. Offline
        • 7.2.3.2. Online
      • 7.2.4. Global Birth Control Pills Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Birth Control Pills (Price)
      • 7.3.1. Global Birth Control Pills by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Birth Control Pills: by Type(USD Billion)
  • Table 2. Birth Control Pills Oral Contraceptives , by Region USD Billion (2015-2020)
  • Table 3. Birth Control Pills Contraceptive Injectable , by Region USD Billion (2015-2020)
  • Table 4. Birth Control Pills: by Application(USD Billion)
  • Table 5. Birth Control Pills Hospital Pharmacy , by Region USD Billion (2015-2020)
  • Table 6. Birth Control Pills Independent Pharmacy , by Region USD Billion (2015-2020)
  • Table 7. Birth Control Pills Online Platform , by Region USD Billion (2015-2020)
  • Table 8. Birth Control Pills Clinics , by Region USD Billion (2015-2020)
  • Table 9. Birth Control Pills: by Purchase Mode(USD Billion)
  • Table 10. Birth Control Pills Offline , by Region USD Billion (2015-2020)
  • Table 11. Birth Control Pills Online , by Region USD Billion (2015-2020)
  • Table 12. South America Birth Control Pills, by Country USD Billion (2015-2020)
  • Table 13. South America Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 14. South America Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 15. South America Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 16. Brazil Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 17. Brazil Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 18. Brazil Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 19. Argentina Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 20. Argentina Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 21. Argentina Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 22. Rest of South America Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 23. Rest of South America Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 24. Rest of South America Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 25. Asia Pacific Birth Control Pills, by Country USD Billion (2015-2020)
  • Table 26. Asia Pacific Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 27. Asia Pacific Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 28. Asia Pacific Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 29. China Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 30. China Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 31. China Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 32. Japan Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 33. Japan Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 34. Japan Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 35. India Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 36. India Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 37. India Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 38. South Korea Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 39. South Korea Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 40. South Korea Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 41. Taiwan Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 42. Taiwan Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 43. Taiwan Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 44. Australia Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 45. Australia Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 46. Australia Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 47. Rest of Asia-Pacific Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 48. Rest of Asia-Pacific Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 49. Rest of Asia-Pacific Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 50. Europe Birth Control Pills, by Country USD Billion (2015-2020)
  • Table 51. Europe Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 52. Europe Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 53. Europe Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 54. Germany Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 55. Germany Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 56. Germany Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 57. France Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 58. France Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 59. France Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 60. Italy Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 61. Italy Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 62. Italy Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 63. United Kingdom Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 64. United Kingdom Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 65. United Kingdom Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 66. Netherlands Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 67. Netherlands Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 68. Netherlands Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 69. Rest of Europe Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 70. Rest of Europe Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 71. Rest of Europe Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 72. MEA Birth Control Pills, by Country USD Billion (2015-2020)
  • Table 73. MEA Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 74. MEA Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 75. MEA Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 76. Middle East Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 77. Middle East Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 78. Middle East Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 79. Africa Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 80. Africa Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 81. Africa Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 82. North America Birth Control Pills, by Country USD Billion (2015-2020)
  • Table 83. North America Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 84. North America Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 85. North America Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 86. United States Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 87. United States Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 88. United States Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 89. Canada Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 90. Canada Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 91. Canada Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 92. Mexico Birth Control Pills, by Type USD Billion (2015-2020)
  • Table 93. Mexico Birth Control Pills, by Application USD Billion (2015-2020)
  • Table 94. Mexico Birth Control Pills, by Purchase Mode USD Billion (2015-2020)
  • Table 95. Birth Control Pills: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Birth Control Pills: by Type(USD Billion)
  • Table 107. Birth Control Pills Oral Contraceptives , by Region USD Billion (2021-2026)
  • Table 108. Birth Control Pills Contraceptive Injectable , by Region USD Billion (2021-2026)
  • Table 109. Birth Control Pills: by Application(USD Billion)
  • Table 110. Birth Control Pills Hospital Pharmacy , by Region USD Billion (2021-2026)
  • Table 111. Birth Control Pills Independent Pharmacy , by Region USD Billion (2021-2026)
  • Table 112. Birth Control Pills Online Platform , by Region USD Billion (2021-2026)
  • Table 113. Birth Control Pills Clinics , by Region USD Billion (2021-2026)
  • Table 114. Birth Control Pills: by Purchase Mode(USD Billion)
  • Table 115. Birth Control Pills Offline , by Region USD Billion (2021-2026)
  • Table 116. Birth Control Pills Online , by Region USD Billion (2021-2026)
  • Table 117. South America Birth Control Pills, by Country USD Billion (2021-2026)
  • Table 118. South America Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 119. South America Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 120. South America Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 121. Brazil Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 122. Brazil Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 123. Brazil Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 124. Argentina Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 125. Argentina Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 126. Argentina Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 127. Rest of South America Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 128. Rest of South America Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 129. Rest of South America Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 130. Asia Pacific Birth Control Pills, by Country USD Billion (2021-2026)
  • Table 131. Asia Pacific Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 132. Asia Pacific Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 133. Asia Pacific Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 134. China Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 135. China Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 136. China Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 137. Japan Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 138. Japan Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 139. Japan Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 140. India Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 141. India Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 142. India Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 143. South Korea Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 144. South Korea Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 145. South Korea Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 146. Taiwan Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 147. Taiwan Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 148. Taiwan Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 149. Australia Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 150. Australia Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 151. Australia Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 152. Rest of Asia-Pacific Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 153. Rest of Asia-Pacific Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 154. Rest of Asia-Pacific Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 155. Europe Birth Control Pills, by Country USD Billion (2021-2026)
  • Table 156. Europe Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 157. Europe Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 158. Europe Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 159. Germany Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 160. Germany Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 161. Germany Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 162. France Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 163. France Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 164. France Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 165. Italy Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 166. Italy Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 167. Italy Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 168. United Kingdom Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 169. United Kingdom Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 170. United Kingdom Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 171. Netherlands Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 172. Netherlands Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 173. Netherlands Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 174. Rest of Europe Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 175. Rest of Europe Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 176. Rest of Europe Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 177. MEA Birth Control Pills, by Country USD Billion (2021-2026)
  • Table 178. MEA Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 179. MEA Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 180. MEA Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 181. Middle East Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 182. Middle East Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 183. Middle East Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 184. Africa Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 185. Africa Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 186. Africa Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 187. North America Birth Control Pills, by Country USD Billion (2021-2026)
  • Table 188. North America Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 189. North America Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 190. North America Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 191. United States Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 192. United States Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 193. United States Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 194. Canada Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 195. Canada Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 196. Canada Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 197. Mexico Birth Control Pills, by Type USD Billion (2021-2026)
  • Table 198. Mexico Birth Control Pills, by Application USD Billion (2021-2026)
  • Table 199. Mexico Birth Control Pills, by Purchase Mode USD Billion (2021-2026)
  • Table 200. Birth Control Pills: by Type(USD/Units)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Birth Control Pills: by Type USD Billion (2015-2020)
  • Figure 5. Global Birth Control Pills: by Application USD Billion (2015-2020)
  • Figure 6. Global Birth Control Pills: by Purchase Mode USD Billion (2015-2020)
  • Figure 7. South America Birth Control Pills Share (%), by Country
  • Figure 8. Asia Pacific Birth Control Pills Share (%), by Country
  • Figure 9. Europe Birth Control Pills Share (%), by Country
  • Figure 10. MEA Birth Control Pills Share (%), by Country
  • Figure 11. North America Birth Control Pills Share (%), by Country
  • Figure 12. Global Birth Control Pills: by Type USD/Units (2015-2020)
  • Figure 13. Global Birth Control Pills share by Players 2020 (%)
  • Figure 14. Global Birth Control Pills share by Players (Top 3) 2020(%)
  • Figure 15. Global Birth Control Pills share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck (United States) Revenue: by Geography 2020
  • Figure 19. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pfizer (United States) Revenue: by Geography 2020
  • Figure 21. Teva Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 22. Teva Pharmaceutical (Israel) Revenue: by Geography 2020
  • Figure 23. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Bayer (Germany) Revenue: by Geography 2020
  • Figure 25. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Allergan (Ireland) Revenue: by Geography 2020
  • Figure 27. Janssen (United States) Revenue, Net Income and Gross profit
  • Figure 28. Janssen (United States) Revenue: by Geography 2020
  • Figure 29. Mankind Pharma (India) Revenue, Net Income and Gross profit
  • Figure 30. Mankind Pharma (India) Revenue: by Geography 2020
  • Figure 31. Piramal Enterprises (India) Revenue, Net Income and Gross profit
  • Figure 32. Piramal Enterprises (India) Revenue: by Geography 2020
  • Figure 33. Reckitt Benckiser (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Reckitt Benckiser (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Church & Dwight (United States) Revenue, Net Income and Gross profit
  • Figure 36. Church & Dwight (United States) Revenue: by Geography 2020
  • Figure 37. Global Birth Control Pills: by Type USD Billion (2021-2026)
  • Figure 38. Global Birth Control Pills: by Application USD Billion (2021-2026)
  • Figure 39. Global Birth Control Pills: by Purchase Mode USD Billion (2021-2026)
  • Figure 40. South America Birth Control Pills Share (%), by Country
  • Figure 41. Asia Pacific Birth Control Pills Share (%), by Country
  • Figure 42. Europe Birth Control Pills Share (%), by Country
  • Figure 43. MEA Birth Control Pills Share (%), by Country
  • Figure 44. North America Birth Control Pills Share (%), by Country
  • Figure 45. Global Birth Control Pills: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Merck (United States)
  • Pfizer (United States)
  • Teva Pharmaceutical (Israel)
  • Bayer (Germany)
  • Allergan (Ireland)
  • Janssen (United States)
  • Mankind Pharma (India)
  • Piramal Enterprises (India)
  • Reckitt Benckiser (United Kingdom)
  • Church & Dwight (United States)
Additional players considered in the study are as follows:
The Female Health Company (United States) , Mayer Laboratories (United States) , Cooper Surgical (United States)
Select User Access Type

Key Highlights of Report


Sep 2021 204 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Birth Control Pills Market Quantitative research analysis
Global Birth Control Pills Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Birth Control Pills market is expected to see a CAGR of 7.4% during projected year 2020 to 2026.
Top performing companies in the Global Birth Control Pills market are Merck (United States), Pfizer (United States), Teva Pharmaceutical (Israel), Bayer (Germany), Allergan (Ireland), Janssen (United States), Mankind Pharma (India), Piramal Enterprises (India), Reckitt Benckiser (United Kingdom) and Church & Dwight (United States), to name a few.
North America is dominating the Birth Control Pills Market.

Know More About Global Birth Control Pills Market Report?

Have a Query? Click Here

Other Related Reports

OTC Drug Comprehensive Study by Type (Class A, Class B), Application (Allergy Prevention & Treatment, Antacids and Acid Reducers, Anticandial, Antihistamines, Antidiarrheal and Laxatives, Anti-fungal...
$ 3450
Biopharmaceutical Logistics Comprehensive Study by Type (Cold Chain Logistics, Non-Cold Chain Logistics), End Users (Clinics, Pharmacies, Hospitals, Pharmaceuticals, Biopharmaceuticals, Supermarkets,...
$ 3450
Amoxicillin Comprehensive Study by Application (Skin Infections, ENT (Ear, Nose & Throat) Infections, Stomach Infections, Lungs Infections, Urinary tract infections (UTI), Pneumonia, Bronchitis, Gono...
$ 3650
Lutein Supplements Comprehensive Study by Nature (Organic, Synthetic), Form (Powder, Tablets, Oil Suspension, Emulsion, Others), Distribution Channel (Online Stores, Medical Stores, Nutraceutical Sto...
$ 3650
Multiple Sclerosis Drugs Comprehensive Study by Type (Clinically Isolated Syndrome (CIS), Relapsing-Remitting MS (RRMS), Primary-Progressive MS (PPMS), Secondary-Progressive MS (SPMS)), Route of Admi...
$ 3450
Dog Care Comprehensive Study by Type (Dog Food, Treats & Chews, Toys & Training, Apparel & Accessories, Grooming & Healthcare, Shelter & Accessories, Other), Application (Young Dogs, Old Dogs), Distr...
$ 3450